Surrozen SRZN
NASDAQ SRZN
$22.76 +0.22 (+0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Surrozen (SRZN) Retained Earnings (2020 - 2026)

Surrozen (SRZN) posted quarterly Retained Earnings of -$654.8 million for Q1 2026, down 305.98% year-over-year from $317.9 million in Q1 2025, and down 24.18% quarter-over-quarter from -$527.3 million in Q4 2025.

Analysis

Surrozen (SRZN) Retained Earnings (2020 - 2026) Analysis & Trends

Surrozen's Retained Earnings history runs 7 years deep, the most recent figure standing at -$654.8 million for Q1 2026.

  • In Q1 2026, Retained Earnings fell 305.98% year-over-year to -$654.8 million; the TTM figure through Mar 2026 stood at -$654.8 million (down 305.98% YoY), while the FY2025 annual figure was -$527.3 million, down 299.82% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$654.8 million, down from -$527.3 million in the prior quarter.
  • The five-year high for Retained Earnings was $317.9 million in Q1 2025, with the low at -$654.8 million in Q1 2026.
  • The 5-year median for Retained Earnings is -$177.9 million (2022), against an average of -$92.8 million.
  • The sharpest annual moves came in 2022 and 2023: Retained Earnings plunged 2670.01% in 2022, then surged 256.45% in 2023.
  • Surrozen's Retained Earnings stood at $254.9 million in 2022, then tumbled by 186.98% to -$221.7 million in 2023, then jumped by 219.03% to $263.9 million in 2024, then plunged by 299.82% to -$527.3 million in 2025, then decreased by 24.18% to -$654.8 million in 2026.
  • Business Quant data shows SRZN's Retained Earnings at -$654.8 million in Q1 2026, -$527.3 million in Q4 2025, and -$344.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Surrozen 263.35 Mn 263.35 Mn - -604.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -604.61 Mn
Mar 31, 2026 -654.80 Mn
Dec 31, 2025 -527.29 Mn
Sep 30, 2025 -344.13 Mn
Jun 30, 2025 319.60 Mn
Mar 31, 2025 317.90 Mn
Dec 31, 2024 -285.26 Mn
Sep 30, 2024 262.89 Mn
Jun 30, 2024 261.85 Mn
Mar 31, 2024 260.66 Mn
Dec 31, 2023 259.63 Mn
Sep 30, 2023 258.31 Mn
Jun 30, 2023 257.39 Mn
Mar 31, 2023 256.03 Mn
Dec 31, 2022 254.90 Mn
Sep 30, 2022 255.79 Mn
Jun 30, 2022 254.69 Mn
Mar 31, 2022 253.68 Mn
Dec 31, 2021 252.46 Mn
Sep 30, 2021 251.44 Mn